| Robert M Potter, MD | |
|
907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 | |
| (865) 981-2335 | |
| (865) 694-4339 |
| Full Name | Robert M Potter |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 41 Years |
| Location | 907 E Lamar Alexander Pkwy, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427096387 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | 17858 (Tennessee) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 17858 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Blount Memorial Hospital | Maryville, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Blount Pathologist Pllc | 1557337508 | 4 |
News Archive
Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients.
A new study published in the journal Nature Communications on 22 October 2019 reports a new approach to cancer treatment that increases the immune capability of T lymphocytes against malignant cancers. This allows the T cells to successfully infiltrate and destroy these tumors. Animal trials have been completed and the researchers are planning clinical trials in human beings next.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior years in asthma-related emergency department (ED) visits at Boston Children's Hospital during the spring 2020 COVID-19 surge and lockdown.
› Verified 2 days ago
| Entity Name | Blount Pathologist Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790739845 PECOS PAC ID: 1557337508 Enrollment ID: O20040909001217 |
News Archive
Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients.
A new study published in the journal Nature Communications on 22 October 2019 reports a new approach to cancer treatment that increases the immune capability of T lymphocytes against malignant cancers. This allows the T cells to successfully infiltrate and destroy these tumors. Animal trials have been completed and the researchers are planning clinical trials in human beings next.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior years in asthma-related emergency department (ED) visits at Boston Children's Hospital during the spring 2020 COVID-19 surge and lockdown.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert M Potter, MD Po Box 51883, Knoxville, TN 37950-1883 Ph: (865) 766-8897 | Robert M Potter, MD 907 E Lamar Alexander Pkwy, Maryville, TN 37804-5015 Ph: (865) 981-2335 |
News Archive
Research led by Queen Mary University of London provides new insight into the mechanisms that lead to uncontrolled inflammation in COVID-19 patients.
A new study published in the journal Nature Communications on 22 October 2019 reports a new approach to cancer treatment that increases the immune capability of T lymphocytes against malignant cancers. This allows the T cells to successfully infiltrate and destroy these tumors. Animal trials have been completed and the researchers are planning clinical trials in human beings next.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced the company has raised $38 million in its latest round of venture financing. New investor Genzyme Ventures joined returning investors New Enterprise Associates, The Novartis Venture Fund, Anthem Capital and Alliance Technology Ventures in the round.
Emperra GmbH E-Health Technologies, specialized in digital health systems and Tele-diabetology, today announced an important further development of the innovative, integrated telemonitoring product system ESYSTA for insulin-dependent diabetes patients.
A new study published online in the Annals of the American Thoracic Society discusses a steep drop off from prior years in asthma-related emergency department (ED) visits at Boston Children's Hospital during the spring 2020 COVID-19 surge and lockdown.
› Verified 2 days ago
Dr. Jonathan L Klein, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 250 E Broadway Ave, Maryville, TN 37804 Phone: 865-380-9746 | |
John R Hilsenbeck Jr., MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-981-2335 Fax: 865-694-4339 | |
James H Vinson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Pkwy, Maryville, TN 37804 Phone: 865-981-2335 Fax: 865-694-4339 | |
Michael D Teague, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 907 E Lamar Alexander Parkway, Maryville, TN 37804 Phone: 865-981-2335 Fax: 865-694-4339 | |
Mark S. Stonecypher, MD PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 250 E Broadway Ave, Mpln, Maryville, TN 37804 Phone: 865-380-9191 | |
Dr. Robert Kane Mccall, MD, MSCR Pathology Medicare: Not Enrolled in Medicare Practice Location: 250 E. Broadway, Maryville, TN 37804 Phone: 865-380-9746 |